Verition Fund Management
RCKT icon

Verition Fund Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Verition Fund Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,197
Closed -$40.1K – 2435
2026
Q1 		$40.1K Buy
+11,197
New +$44.5K ﹤0.01% 2119
2025
Q2 		– Sell
-99,664
Closed -$665K – 3820
2025
Q1 		$665K Buy
99,664
+73,697
+284% +$728K ﹤0.01% 2390
2024
Q4 		$326K Buy
25,967
+10,286
+66% +$155K ﹤0.01% 2734
2024
Q3 		$290K Buy
+15,681
New +$321K ﹤0.01% 2662
2021
Q1 		– Sell
-12,329
Closed -$676K – 1735
2020
Q4 		$676K Buy
+12,329
New +$449K 0.01% 584

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Verition Fund Management's RCKT Position: Q2 2026 in Review

Verition Fund Management sold out of Rocket Pharmaceuticals (RCKT) in Q2 2026, closing a stake of 11,197 shares — an estimated $40.1K sold.

Verition Fund Management first reported a position in RCKT in Q4 2020 and held it in 5 quarters. The position peaked at $676K in Q4 2020. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Verition Fund Management reported no remaining Rocket Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Verition Fund Management sold 11,197 Rocket Pharmaceuticals shares in Q2 2026, an estimated $40.1K.
  • Verition Fund Management first reported a position in Rocket Pharmaceuticals in Q4 2020 and held it in 5 quarters.
  • Verition Fund Management's Rocket Pharmaceuticals position peaked at $676K in Q4 2020.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.